FDA Approves BUTORPHANOL TARTRATE — Hospira, Inc.

Hospira, Inc. obtained FDA approval for the ANDA074626 generic version of butorphanol tartrate, likely introducing a competitive alternative to the current market leader, which could drive down pricing and increase access for the intramuscular analgesic.